Skip to main content
Clinical Trials/NCT04362345
NCT04362345
Unknown
Not Applicable

Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia in France

University Hospital, Strasbourg, France1 site in 1 country100 target enrollmentApril 9, 2020
ConditionsCovid-19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid-19
Sponsor
University Hospital, Strasbourg, France
Enrollment
100
Locations
1
Primary Endpoint
Identification of risk factors for severity (death or transfer to resuscitation) of Covid-19 infection
Last Updated
5 years ago

Overview

Brief Summary

The aim of the research is to improve patient management by rapidly identifying, based on the terrain and clinical and biological characteristics, those patients likely to present a severe form of ARDS at risk of leading to intensive care

Registry
clinicaltrials.gov
Start Date
April 9, 2020
End Date
January 9, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Major patient (≥18 years of age)
  • Admitted in March 2020 for confirmed Covid-19 lung disease (nasopharyngeal smear or sputum with SARS-CoV-2 positive PCR).

Exclusion Criteria

  • Patient who has expressed opposition to participation in the study.
  • Mild forms of infection that do not require hospitalization,
  • Subject under safeguard of justice
  • Subject under guardianship or trusteeship

Outcomes

Primary Outcomes

Identification of risk factors for severity (death or transfer to resuscitation) of Covid-19 infection

Time Frame: Files analysed retrospectively from March 1st, 2020 to April 15, 2020 will be examined]

Study Sites (1)

Loading locations...

Similar Trials